Abalone Bio
YC W20 ↗San Francisco, US · Founded 2018 · 14 employees · 4 known investors
Abalone Bio develops target-activating antibodies for difficult-to-drug disease targets by combining engineered biology with machine learning. The company uses large-scale biological measurement platforms and AI-powered sequence analysis to discover functional antibody drugs for pharmaceutical and biotechnology applications.
AI & Machine LearningBiotechDeep TechHealthtechMachine LearningSynthetic BiologyTherapeuticsDrug discoveryin /18295627@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (W20)
RY
Richard YuinFounder
GP
Gustavo PesceinFounder
Investors · 4
In the news
- The Abalone Bio Investment Thesis | Gravity Fundgravityfund.vc · 2022
- NDFS17 Video: Abalone Bio’s Pathway to Granting Success - FreeMind Groupfreemindgroup.com · 2022